KRAS and colorectal carcinoma: Some studies have used ML techniques to diagnose KRAS mutation status in CRC, revealing that DL can not only assess microsatellite instability to predict chemotherapy responses [17] but also integrate imaging, genomic, and clinical data to accurately diagnose KRAS mutations, thereby facilitating personalized targeted therapies [18].